Cargando…
MYC Expression and Metabolic Redox Changes in Cancer Cells: A Synergy Able to Induce Chemoresistance
Chemoresistance is due to multiple factors including the induction of a metabolic adaptation of tumor cells. In fact, in these cells, stress conditions induced by therapies stimulate a metabolic reprogramming which involves the strengthening of various pathways such as glycolysis, glutaminolysis and...
Autores principales: | Marengo, Barbara, Garbarino, Ombretta, Speciale, Andrea, Monteleone, Lorenzo, Traverso, Nicola, Domenicotti, Cinzia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6614970/ https://www.ncbi.nlm.nih.gov/pubmed/31341534 http://dx.doi.org/10.1155/2019/7346492 |
Ejemplares similares
-
PKCα Inhibition as a Strategy to Sensitize Neuroblastoma Stem Cells to Etoposide by Stimulating Ferroptosis
por: Monteleone, Lorenzo, et al.
Publicado: (2021) -
Etoposide-resistance in a neuroblastoma model cell line is associated with 13q14.3 mono-allelic deletion and miRNA-15a/16-1 down-regulation
por: Marengo, Barbara, et al.
Publicado: (2018) -
Role of Glutathione in Cancer Progression and Chemoresistance
por: Traverso, Nicola, et al.
Publicado: (2013) -
Biological evaluation of pyrazolyl-urea and dihydro-imidazo-pyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma
por: Marengo, Barbara, et al.
Publicado: (2020) -
Correction: Biological evaluation of pyrazolyl-urea and dihydro-imidazo-pyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma
por: Marengo, Barbara, et al.
Publicado: (2023)